Researchers from the Peter MacCallum Cancer Centre in Melbourne, Australia, have found that a N-methyl-2-pyrrolidone (NMP), a common solvent used in a wide array of industrial and medical products, has cancer-fighting properties. The discovery came about thanks to an observant researcher, and now the solvent is set to be put to the test in a world-first clinical trial on patients with advanced blood cancer... Continue Reading Common solvent found to have anti-cancer properties